PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27992676-9	2017	Moreover, simultaneous administration of CoPP and peg-IFNalpha reduced viraemia even stronger (median 3log), whereas 1log viraemia reduction was determined in mice receiving peg-IFNalpha monotherapy.	Polyethylene Glycols	50-53	interferon alpha	Mus musculus	54-62	
27152679-4	2016	Herein, we report site-specific in situ growth (SIG) of a PEG-like polymer, poly(oligo(ethylene glycol) methyl ether methacrylate) (POEGMA), from the C-terminus of interferon-alpha to form a site-specific (C-terminal) and stoichiometric (1:1) POEGMA conjugate of interferon-alpha in high yield.	Polyethylene Glycols	58-61	interferon alpha	Mus musculus	164-180	
27152679-4	2016	Herein, we report site-specific in situ growth (SIG) of a PEG-like polymer, poly(oligo(ethylene glycol) methyl ether methacrylate) (POEGMA), from the C-terminus of interferon-alpha to form a site-specific (C-terminal) and stoichiometric (1:1) POEGMA conjugate of interferon-alpha in high yield.	Polyethylene Glycols	58-61	interferon alpha	Mus musculus	263-279	
21872329-1	2011	Interferon alpha (IFNalpha) conjugated with polyethylene glycol (PEG) has been widely used for the treatment of hepatitis C virus (HCV) infection as a once-a-week injection formulation.	Polyethylene Glycols	44-63	interferon alpha	Mus musculus	18-26	
21872329-1	2011	Interferon alpha (IFNalpha) conjugated with polyethylene glycol (PEG) has been widely used for the treatment of hepatitis C virus (HCV) infection as a once-a-week injection formulation.	Polyethylene Glycols	65-68	interferon alpha	Mus musculus	18-26